PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Stress degradation studies and development of validated stability indicating densitometric method for estimation of alpha lipoic acid in bulk and capsule dosage form

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
A precise, sensitive, specific and accurate stability indicating densitometric method was developed and validated for alpha-lipoic acid (ALA) in bulk and capsule dosage form. The study employed pre-coated silica gel 60F254 TLC plates as stationary phase and toluene: chloroform: methanol: formic acid (5:3:1:0.05; v/v/v/v) as mobile phase. The developed method furnished compact spots of alpha-lipoic acid (Rf 0.28 ± 0.05) after derivatization, offered good linearity in range 80–400 ng/spot with correlation coefficient of 0.998. The values for detection and quantitation were found 18.022 and 54.612 ng/spot respectively. ALA was subjected to stress degradation studies and total 13 degradation products were resolved. Thus, the proposed method offered good results according to ICH guidelines, and can be used for identification, routine quantitative determination as well as for monitoring the stability of ALA in bulk and in capsules.
Rocznik
Strony
180--186
Opis fizyczny
Bibliogr. 24 poz., rys., tab., wykr.
Twórcy
  • Department of Pharmaceutical Chemistry, Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Noida, U.P., India
  • Department of Pharmaceutical Chemistry, Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Noida, U.P., India
  • Department of Pharmacy, SGSITS Indore, Madhya Pradesh, 452003, India
Bibliografia
  • 1. Blessy, M.R.; Patel, R.D.; Prajapati, P.N.; Agrawal, Y.K. Development of forced degradation and stability indicating studies of drugs -A review. J. Pharm. Anal. 2014, 4(3), 159–65.
  • 2. Henry, T.R.; Penn, L.D.; Conerty, J.R.; Wright, F.E.; Gorman, G.; Pack, B.W. Best practices in stability indicating method development and validation for non-clinical dose formulations. AAPS J. 2016, 18(6), 1418–23.
  • 3. Carreau, J.P. Biosynthesis of lipoic acid via unsaturated fatty acids. Methods Enzymol. 1979, 62, 152–8, Academic Press.
  • 4. Packer, L.; Witt, E.H.; Tritschler, H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 1995, 9(2), 227–50.
  • 5. Rochette, L.; Ghibu, S.; Muresan, A.; Vergely, C. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can. J. Physiol. Pharmacol. 2015, 93(12), 1021–7.
  • 6. Handelman, G.J.; Han, D.; Tritschler, H.; Packer, L. a-Lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem. Pharmacol. 1994, 47(10), 1725–30.
  • 7. El Barky, A.R.; Hussein, S.A.; Mohamed, T.M. The potent antioxidant alpha lipoic acid. J. Plant Chem. Ecophysiol. 2017, 2, 1016.
  • 8. Attia, M.; Essa, E.A.; Zaki, R.M.; Elkordy, A.A. An overview of the antioxidant effects of ascorbic acid and alpha lipoic acid (in liposomal forms) as adjuvant in cancer treatment. Antioxidants 2020, 9(5), 359.
  • 9. Gomes, M.B.; Negrato, C.A. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetology Metab. Syndr. 2014, 6(1), 1–8.
  • 10. Shay, K.P.; Moreau, R.F.; Smith, E.J.; Smith, A.R.; Hagen, T.M. Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim. Biophys. Acta (BBA)-General Subjects 2009, 1790(10), 1149–60.
  • 11. Dhaneshwar, S.R. Pharmaceutical Applications of High-Performance Thin Layer Chromatography; Instrumental Thin-Layer Chromatography; Elsevier, 2015; pp 451–78.
  • 12. Zlatkis, A.; Kaiser, R.E. HPTLC-high Performance Thin-Layer Chromatography; Elsevier, 2011.
  • 13. Patni, M.; Rawat, S Analytical method development and validation for estimation of alpha lipoic acid in bulk and pharmaceutical dosage form by UV spectrometric method. J. Biol. Chem. Chron. 2018, 4(1), 67–70.
  • 14. Veeraswami, B.; Naveen, V.M.K. Development and validation of stability indicating assay of Alpha lipoic acid and Enzogenol by UPLC and its degradation. J. Emerging Tech. Innovative Res. 2019, (6), 651.
  • 15. Papageorgiou, S.; Varvaresou, A.; Panderi, I.; Giannakou, M.; Spiliopoulou, C.; Athanaselis, S. Development and validation of a reversed-phase high-performance liquid chromatographic method for the quantitation and stability of a-lipoic acid in cosmetic creams. Int. J. Cosmet. Sci. 2020, 42(3), 221–8.
  • 16. Dolinina, E.S.; Akimsheva, E.Y.; Parfenyuk, E.V. Development of novel silica-based formulation of a-lipoic acid: evaluation of photo and thermal stability of the encapsulated drug. Pharmaceutics 2020, 12(3), 228.
  • 17. Viana, C.; Ribeiro, S.M.; Moreira, A.P.; Müller, L.S.; Motta, M.J.; Monserrat, J.M.; Carvalho, L.M.; Bohrer, D. Quantification of alpha lipoic acid in pharmaceutical products by HPLC with pulsed amperometric detection at a gold electrode. Curr. Anal. Chem. 2019, 15(6), 694–700.
  • 18. Chandak, D.; Sharma, P. Development and validation for simultaneous estimation of gabapentin, mecobalamin and alpha lipoic acid in tablet formulation. Res. J. Sci. Technol 2020, 12(1), 74–8.
  • 19. Borowczyk, K.; Olejarz, P.; Chwatko, G.; Szylberg, M.; Głowacki, R. A simplified method for simultaneous determination of α-lipoic acid and low-molecular-mass thiols in human plasma. Int. J. Mol. Sci. 2020, 21(3), 1049.
  • 20. Kothari, I.R.; Italiya, K.S.; Sharma, S.; Mittal, A.; Chitkara, D. A rapid and precise liquid chromatographic method for simultaneous determination of alpha lipoic acid and docetaxel in lipid-based nano formulations. J. Chromatogr. Sci. 2018, 56(10), 888–94.
  • 21. Kumar, S.A.; Debnath, M.; Rao, J.V.; Sankar, D.G. Stability indicating analytical method development and validation for simultaneous estimation of pregabalin, mecobalamin and alpha lipoic acid in bulk as well as in pharmaceutical dosage form by using RP-HPLC. Res. J. Pharm. Technol 2014, 7(9), 1004–13.
  • 22. Patel, P.J.; Hinge, M. Simultaneous estimation of metformin hydrochloride and alpha lipoic acid by HPTLC method in tablet dosage form. Adv. Pharmacoepidemiol. Drug Saf. 2020, (9), 1–4.
  • 23. Stability Testing of New Drug Substances and Products; ICH Harmonized Tripartite Guideline Q1A(R2): 2003.
  • 24. Validation of Analytical Procedures: Text and Methodology; ICH Harmonized Tripartite Guideline Q2 (R1): Geneva, 2005.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-d7028b4a-69b7-4854-860d-52d50700eb0b
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.